UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom.

Global demand for protein will double in the next few decades. The only way to meet this demand in a way that is both respectful of animal well being and preserves or increases wild spaces is to make livestock that are better adapted to their environment, and which use fewer resources to produce the same amount of protein. In this way, their solutions can help the livestock, the planet, and the producer, all at the same time. See the video presentation or the links below for an overview of their current projects.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

KeyGene NV provides its partners and customers in the plant breeding industry contract research, partnerships and molecular genetic services. It delivers novel enabling technologies and applications to support companies and institutes that carry out fundamental or applied genetic genomic research and that seek to enhance the quality of their products through the improvement of their genetic material. The company was established in 1989 and is headquartered in Wageningen, the Netherlands.

Acceligen is a precision breeding company that addresses long-standing challenges in animal health and wellbeing. It combines the best knowledge of genetics with the capability to precisely deliver these natural traits and dramatically speed-up the genetic improvement of plants and animals used for food. The company's ability to precisely deliver traits based on gene editing technology provides animal breeders new opportunities to accelerate genetic improvement. By introducing unique and valuable genetics, they can dramatically shorten the development cycles typical with conventional selective breeding. Acceligen was founded in 2014 and is headquartered in Eagan, Minnesota, USA.

Guangzhou Shenglu Biotechnology Co., Ltd., established on 2014-01-09, Business scope includes biotechnology development services;Biotechnology Consulting,communication service;Medical Research and Experimental Development;Biotechnology Transfer Services;Cosmetic Manufacturing;Wholesale of cosmetics and hygiene products;Retailing of cosmetics and hygiene products;Manufacturing of organic chemical raw materials(Monitor Chemicals,Excluding hazardous chemicals);Manufacturing of other non-hazardous basic chemical raw materials;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);

Shenzhen New Industries Biomedical Engineering Co., Ltd. principally engages in the research, development, production, and sale of automatic chemiluminescence immunoassay instruments and supporting reagents. The company was founded on December 15, 1995 and is headquartered in Shenzhen, China.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Develops and manufactures agricultural and noncrop products

Polus is a biopharmaceutical company specializing in solutions for medical equality. It provides therapeutic protein-based biosimilar products using large scales cell-culture technology to carry out global commercialization. The company's mission to transform the paradigm of the biopharmaceutical industry standards by making high-quality biological drugs at an affordable price for all patients in the world. Polus was founded in 2016 and is headquartered in Incheon, Inch'on-jikhalsi, South Korea.

Zhejiang Hilong Biotechnology Co., Ltd., established on 2012-11-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology Import and Export;Sales of Class II Medical Devices;Conference and Exhibition Services;Domestic trade agent;Inspection business;Health Consulting Services(Does not include medical services);pet service(No Animal Treatment)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Veterinary drug production;Animal Clinic;Pharmaceutical commissioned production;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.

Jiangsu Nannong High-Tech Co., Ltd., established on 2000-12-12, The scope of business includes research and development of agricultural biological high-tech products,manufacture,Sales;Live embryotoxin vaccine production line,Cytotoxic live vaccine production line,Production line of embryotoxin inactivated vaccine,Cytotoxic inactivated vaccine production line(2strip),Bacterial Live Vaccine Production Line,Production of Bacterial Inactivated Vaccine Production Line;Agricultural high-tech transfer,technical consulting;Using self-owned funds to invest abroad;road general cargo transportation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Keqian Biology is involved in the research and development, production, and sale of veterinary biological products, as well as the provision of technical services for the prevention of animal epidemics. They offer products including a combination vaccine, a vaccine for poultry, a pet vaccine, and a diagnostic reagent.